Clinical Scorecard: Association Between Iron Levels and Insulin Resistance in US Adults: Insights from a Nationwide Population Study
At a Glance
Category
Detail
Condition
Insulin Resistance (IR)
Key Mechanisms
Iron status markers including serum iron, transferrin saturation, serum transferrin receptor, and iron intake influence insulin resistance through their roles in cellular iron homeostasis and metabolism.
Target Population
US adults aged 18 years and older
Care Setting
Population health and clinical research settings; potential implications for primary care and endocrinology
Key Highlights
Serum iron (SI) and transferrin saturation (TSAT) are negatively correlated with insulin resistance, indicating higher iron levels associate with lower IR risk.
Serum transferrin receptor (sTfR) and iron intake show a positive correlation with insulin resistance.
Transferrin saturation (TSAT) demonstrated superior predictive value for insulin resistance compared to other iron biomarkers.
Guideline-Based Recommendations
Diagnosis
Use multiple iron status biomarkers (iron intake, serum iron, serum ferritin, hemoglobin, serum transferrin receptor, transferrin saturation) to comprehensively assess iron status in relation to insulin resistance.
Define insulin resistance using HOMA-IR with a cutoff value ≥2.5.
Management
Consider monitoring iron status as part of metabolic health assessments in adults at risk for insulin resistance.
Address iron deficiency or overload cautiously, recognizing their potential impact on insulin sensitivity.
Monitoring & Follow-up
Regularly evaluate serum iron, transferrin saturation, and serum transferrin receptor levels to monitor iron status and its relationship to insulin resistance.
Use receiver operating characteristic (ROC) analysis to assess predictive biomarkers for insulin resistance risk stratification.
Risks
Iron deficiency may contribute to anemia and associated complications such as fatigue and immune dysfunction.
Iron overload is implicated in increased risk of diabetes mellitus and cardiovascular diseases.
Patient & Prescribing Data
US adult population aged 18 years and older without pregnancy
Iron status biomarkers can inform risk stratification for insulin resistance; however, clinical interventions should balance risks of iron deficiency and overload.
Clinical Best Practices
Employ a comprehensive panel of iron biomarkers rather than a single indicator to evaluate iron status in patients with or at risk for insulin resistance.
Interpret iron status in the context of confounding factors such as age, sex, BMI, and physical activity.
Utilize HOMA-IR as a standardized measure for insulin resistance in clinical and research settings.
Recognize the nonlinear dose–response relationships between iron markers and insulin resistance when assessing patient risk.
A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.
